IMARC Group latest research study “Prostate Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global prostate cancer treatment market size reached US$ 7.2 Billion in 2022. Looking forward, the market is expected to reach US$ 10.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

Prostate cancer is a type of severe malignant tumor caused by uncontrollable division and expansion of numerous abnormal cells in the prostate gland. It is diagnosed by clinical laboratory examination, digital rectal exam (DRE), prostate-specific antigen (PSA) test, transrectal ultrasound, transrectal magnetic resonance imaging (MRI), urine testing, and tissue biopsy. It can be treated with numerous therapeutic procedures such as medications, vaccines, and treatments, including immunotherapy, radiation, cryotherapy, surgery, chemotherapy, and biological and hormone therapy, by mitigating the spread of cancer cells in the body. At present, the growing prevalence of prostate cancer is escalating the demand for prostate cancer treatment across the globe.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/prostate-cancer-treatment-market/requestsample

Prostate Cancer Treatment Market Trends and Drivers:

The market is primarily driven by the growing instances of prostate cancer, especially amongst the geriatric population. In addition, the rising awareness regarding numerous prostate cancer treatment options is contributing to the market growth.

Moreover, various technological advancements, including the introduction of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for diagnosing prostate cancer at early stages, represent another major growth-inducing factor.

Besides this, several governments are taking initiatives to integrate medical reimbursement policies and patient assistance programs (PAPs) that offer financial assistance to patients by providing free medications and treatment, providing a positive thrust to the market growth.

Furthermore, extensive investment in research and development (R&D) activities, mergers and acquisitions, and novel product launches such as PaigeProstate, a clinical-grade artificial intelligence (AI) solution for prostate cancer detection, are creating a favorable market outlook across the globe.

Global Prostate Cancer Treatment Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Prostate Cancer Treatment Companies:

Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.

The report has segmented the market on the basis of drug type and distribution channel.

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=6185&flag=C

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Reports:

Mobile Imaging Services Market Size 2022 | Trends, Analysis, Industry Report 2027

Biscuits Market Share 2022 | Business Analysis, Industry Report, Trends and Forecast to 2027

Field Programmable Gate Array Market Size 2023 | Share, Growth, Report, 2028

Folding Furniture Market Share 2022 | Industry Report, Growth and Forecast to 2027

Healthcare BPO Market Share 2023 | Industry Trends, Drivers and Opportunities 2028

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800